Abstract
The effect of the antiepileptic drug topiramate on Ca2+ uptake through (RS)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionate (AMPA) and kainate (KA) receptors was investigated in different cell culture systems consisting of neurons from the cerebral cortex, hippocampus, and cerebellum. Ca2+ influx was assayed using a fluorescent Ca2+ chelator to monitor changes in the intracellular Ca2+ concentration or cobalt staining to assess the effect of topiramate on Ca2+-permeable AMPA/KA receptors. In all types of neuronal cultures studied, AMPA and KA were found to elicit an influx of Ca2+ in a subset of the neuronal population. Topiramate, at concentrations of 30 and 100 μM, inhibited Ca2+ influx by up to 60%. Modulation of AMPA and KA-evoked Ca2+ influx may contribute to both the antiepileptic and neuroprotective properties of topiramate.
Similar content being viewed by others
REFERENCES
Löscher, W. 1998. New visions in the pharmacology of anticonvulsion. Eur. J. Pharmacol. 342:1–13.
Zona, C., Giotti, M. T., and Avoli, M. 1997. Topiramate attenuates voltage-gated sodium currents in rat cerebellar granule cells. Neurosci. Lett. 231:123–126.
White, H. S., Brown, S. D., Woodhead, J. H., Skeen, G. A., and Wolf, H. H. 1997. Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold. Epilepsy Res. 28:167–179.
Gibbs, J. W. III, Sombati, S., DeLorenzo, R. J., and Coulter, D. A. 2000. Cellular actions of topiramate: Blockade of kainate-evoked inward currents in cultured hippocampal neurons. Epilepsia 41: S10–S16.
McLean, M. J., Bukhari, A. A., and Wamil, A. W. 2000. Effects of topiramate on sodium-dependent action-potential firing by mouse spinal cord neurons in cell culture. Epilepsia 41: S21–S24.
Zhang, X.-L., Velumian, A. A., Jones, O. T., and Carlen, P. L. 2000. Modulation of high-voltage-activated calcium channels in dentate granule cells by topiramate. Epilepsia 41:S52–S60.
Skradski, S. and White, H. S. 2000. Topiramate blocks kainate-evoked cobalt influx into cultured neurons. Epilepsia 41:S45–S47.
White, H. S. 2002. Topiramate: Mechanisms of action. Pages 719–726, in Levy, R. H., Mattson, R. H., Meldrum, B. S., and Perucca, E. (eds.), Antiepileptic drugs, 5th ed., Philadelphia, PA: Lippincott Williams & Wilkins.
Sarup, A. and Schousboe, A. 2002. Alterations in glutamate transporter protein expression and activity in cultures of astrocytes after topiramate treatment. Epilepsia 43:S136–S137.
Schousboe, A. 1990. Neurochemical alterations associate with epilepsy or seizure activity. Pages 1–16, in Dam, M. and Gram, L. (eds.), Comprehensive epileptology, New York: Raven Press.
Shank, R. P., Gardocki, J. F., Streeter, A. J., and Maryanoff, B. E. 2000. An overview of the preclinical aspects of topiramate: Pharmacology, pharmacokinetics, and mechanism of action. Epilepsia 41:S3–S9.
Sommer, B. 1997. Ionotropic glutamate receptors. Pages 81–98, in Monaghan, D. T. and Wenthold, R. J. (eds.), The ionotropic glutamate receptors, NJ: Humana Press.
Frandsen, A. and Schousboe, A. 1993. Excitatory amino acid mediated cytotoxicity and calcium homeostasis in cultured neurons. J. Neurochem. 60:1202–1211.
Frandsen, A. and Schousboe, A. 2003. AMPA receptor mediated neurotoxicity: Role of Ca2+ and desensitisation. Neurochem. Res. 28:1493–1497.
Partin, K. M., Patneau, D. K., and Mayer, M. L. 1994. Cyclothiazide differentially modulates desensitization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor splice variants. Mol. Pharmacol. 46:129–138.
Lodge, D. 1997. Subtypes of glutamate receptors. Pages 1–38, in Monaghan, D. T. and Wenthold, R. J. (eds.), The ionotropic glutamate receptors, NJ: Humana Press.
Pruss, R. M., Akeson, R. L., Racke, M. M., and Wilburn, J. L. 1991. Agonist-activated cobalt uptake identifies divalent cation-permeable kainate receptors on neurons and glial cells. Neuron 7:509–518.
Drejer, J., Honoré, T., and Schousboe, A. 1987. Excitatory amino acid induced release of 3H-GABA from cultured mouse cerebral cortex interneurons. J. Neurosci. 7:2910–2916.
Drejer, J. and Schousboe, A. 1989. Selection of a pure cerebellar granule cell culture by kainate treatment. Neurochem. Res. 14:751–754.
Hertz, E., Yu, A. C. H., Hertz, L., Juurlink, B. H. J., and Schousboe, A. 1989. Preparation of primary cultures of mouse cortical neurons. Pages 183–186, in Shahar, A., De Vellis, J., Vernadakis, A., and Haber, B. (eds.), A dissection and tissue culture manual for the nervous system, New York: Alan R. Liss.
Schousboe, A., Meier, E., Drejer, and Hertz, L. 1989. Preparation of primary cultures of mouse (rat) cerebellar granule cells. Pages 203–206, in Shahar, A., De Vellis, J., Vernadakis, A., and Haber, B. (eds.), A dissection and tissue culture manual of the nervous system, New York: Alan R. Liss.
Hertz, L., Juurlink, B. H. J., Fosmark, H., and Schousboe, A. 1982. Astrocytes in primary cultures. Pages 175–186, in Pfeiffer, S. E. (ed.), Neuroscience approached through cell culture, Boca Raton, FL: CRC Press.
Mattson, M. P. 1994. Secreted forms of beta-amyloid precursor protein modulate dendrite outgrowth and calcium responses to glutamate in cultured embryonic hippocampal neurons. J. Neurobiol. 25:439–450.
Niebauer, M. and Gruenthal, M. 1999. Topiramate reduces neuronal injury after experimental status epilepticus. Brain Res. 837: 263–269.
Yang, Y., Shuaib, A., Li, Q., and Siddiqui, M. M. 1998. Neuroprotection by delayed administration of topiramate in a rat model of middle cerebral artery embolization. Brain Res. 804: 169–176.
Lee, S. R., Kim, S. P., and Kim, J. E. 2000. Protective effect of topiramate against hippocampal neuronal damage after global ischemia in the gerbils. Neurosci. Lett. 281:183–186.
Koh, S. and Jensen, F. E. 2001. Topiramate blocks perinatal hypoxia-induced seizures in rat pups. Ann. Neurol. 50:366–372.
Yoneda, S., Tanaka, E., Goto, W., Ota, T., and Hara, H. 2003. Topiramate reduces excitotoxic and ischemic injury in the rat retina. Brain Res. 967:257–266.
Maragakis, N. J., Jackson, M., Ganel, R., and Rothstein, J. D. 2003. Topiramate protects against motor neuron degeneration in organotypic spinal cord cultures but not in G93A SOD1 transgenic mice. Neurosci. Lett. 338:107–110.
Smith-Swintosky, V. L., Zhao, B., Shank, R. P., and Plata-Salaman, C. R. 2001. Topiramate promotes neurite outgrowth and recovery of function after nerve injury. Neuroreport 12:1031–1034.
Murphy, S. N. and Miller, R. J. 1988. A glutamate receptor regulates Ca2+ mobilization in hippocampal neurons. Proc. Natl. Acad. Sci. USA 85:8737–8741.
Murphy, S. N. and Miller, R. J. 1989. Two distinct quisqualate receptors regulate Ca2+ homeostasis in hippocampal neurons in vitro. Mol. Pharmacol. 35:671–680.
Frandsen, A. and Schousboe, A. 1992. Mobilization of dantrolene-sensitive intracellular calcium pools is involved in the cytotoxicity induced by quisqualate and N-methyl-<small-caps>D</small-caps>-aspartate but not by 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionate and kainate in cultured cerebral cortical neurons. Proc. Natl. Acad. Sci. USA 89:2590–2594.
Ogura, A., Nakazawa, M., and Kudo, Y. 1992. Further evidence for calcium permeability of non-NMDA receptor channels in hippocampal neurons. Neurosci. Res. 12:606–616.
Witt, M.-R., Dekermendjian, K., Frandsen, A., Schousboe, A., and Nielsen, M. 1994. Complex correlation between excitatory amino acid induced increase in the intracellular Ca2+ concentration and subsequent loss of neuronal function in individual neocortical neurons in culture. Proc. Natl. Acad. Sci. USA 91: 12303–12307.
Jensen, J. B., Schousboe, A., and Pickering, D. 1999. Role of desensitization and subunit expression for kainate receptor-mediated neurotoxicity in murine neocortical cultures. J. Neurosci. Res. 55:208–217.
Zhou, N., Taylor, D. A., and Parks, T. N. 1995. Cobalt-permeable non-NMDA receptors in developing chick brainstem auditory nuclei. Neuroreport 6:2273–2276.
Savidge, J. R., Bleakman, D., and Bristow, D. R. 1997. Identification of kainate receptor-mediated intracellular calcium increases in cultured rat cerebellar granule cells. J. Neurochem. 69: 1763–1766.
Jensen, J. B., Lund, T. M., Timmermann, D. B., Schousboe, A., and Pickering, D. S. 2001. Role of GluR2 expression in AMPA-induced toxicity in cultured murine cerebral cortical neurons. J. Neurosci. Res. 65:267–277.
Jensen, J. B., Schousboe, A., and Pickering, D. 1998. Development of calcium-permeable α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors in cultured neocortical neurons visualized by cobalt staining. J. Neurosci. Res. 54:273–281.
Turetsky, D. M., Canzoniero, L. M., Sensi, S. L., Weiss, J. H., Goldberg, M. P., and Choi, D. W. 1994. Cortical neurones exhibiting kainate-activated Co2+ uptake are selectively vulnerable to AMPA/kainate receptor-mediated toxicity. Neurobiol. Dis. 1: 101–110.
Smith, L., Price-Jones, M., Hughes, K., Egebjerg, J., Poulsen, F., Wiberg, F. C., and Shank, R. P. 2000. Effects of topiramate on kainate-and domoate-activated [14C]guanidinium ion flux through GluR6 channels in transfected BHK cells using cytostar-T scintillating microplates. Epilepsia 41:S48–S51.
Gryder, D. S. and Rogawski, M. A. 2002. Topiramate selectively blocks GluR5 kainate receptor-mediated excitatory synaptic transmission in amygdala: Evidence for indirect action via modulation of protein kinase A-dependent phosphorylation. Epilepsia 43: S129.
Garnett, W. R. 2000. Clinical pharmacology of topiramate: A review. Epilepsia 41:S61–S65.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Poulsen, C.F., Simeone, T.A., Maar, T.E. et al. Modulation by Topiramate of AMPA and Kainate Mediated Calcium Influx in Cultured Cerebral Cortical, Hippocampal and Cerebellar Neurons. Neurochem Res 29, 275–282 (2004). https://doi.org/10.1023/B:NERE.0000010456.92887.3b
Issue Date:
DOI: https://doi.org/10.1023/B:NERE.0000010456.92887.3b